Literature DB >> 29174479

Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement.

S Borot1, P Y Benhamou2, C Atlan3, E Bismuth4, E Bonnemaison5, B Catargi6, G Charpentier7, A Farret8, N Filhol9, S Franc10, D Gouet11, B Guerci12, I Guilhem13, C Guillot14, N Jeandidier15, M Joubert16, V Melki17, E Merlen18, A Penfornis19, S Picard20, E Renard8, Y Reznik15, J P Riveline19, S Rudoni20, P Schaepelynck9, A Sola-Gazagnes21, N Tubiana-Rufi4, O Verier-Mine22, H Hanaire16.   

Abstract

The use by diabetes patients of real-time continuous interstitial glucose monitoring (CGM) or the FreeStyle Libre® (FSL) flash glucose monitoring (FGM) system is becoming widespread and has changed diabetic practice. The working group bringing together a number of French experts has proposed the present practical consensus. Training of professionals and patient education are crucial for the success of CGM. Also, institutional recommendations must pay particular attention to the indications for and reimbursement of CGM devices in populations at risk of hypoglycaemia. The rules of good practice for CGM are the precursors of those that need to be enacted, given the oncoming emergence of artificial pancreas devices. It is necessary to have software combining user-friendliness, multiplatform usage and average glucose profile (AGP) presentation, while integrating glucose and insulin data as well as events. Expression of CGM data must strive for standardization that facilitates patient phenotyping and their follow-up, while integrating indicators of variability. The introduction of CGM involves a transformation of treatment support, rendering it longer and more complex as it also includes specific educational and technical dimensions. This complexity must be taken into account in discussions of organization of diabetes care.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Continuous glucose monitoring; Flash glucose monitoring; Guidelines; Patient education; Subcutaneous insulin infusion; Type 1 diabetes; Type 2 diabetes

Mesh:

Year:  2017        PMID: 29174479     DOI: 10.1016/j.diabet.2017.10.009

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  12 in total

1.  Distribution of Highly Prevalent Musculoskeletal Disorders and Their Association With Diabetes Complications in a Population of 140 Individuals With Type 1 Diabetes: A Retrospective Study in a French Diabetes Center.

Authors:  Sylvie Picard; Dimitar Vasilevski; Guy Fagherazzi
Journal:  Clin Diabetes       Date:  2020-04

2.  An Opportunity to Increase the Benefit of CGM Usage: The Need to Train the Patients Adequately.

Authors:  Lutz Heinemann; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2019-12-26

3.  Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.

Authors:  Anna Lilja Secher; Ulrik Pedersen-Bjergaard; Ole L Svendsen; Birthe Gade-Rasmussen; Thomas Almdal; Linda Raimond; Dorte Vistisen; Kirsten Nørgaard
Journal:  Diabetologia       Date:  2021-09-08       Impact factor: 10.122

Review 4.  Selecting the Appropriate Continuous Glucose Monitoring System - a Practical Approach.

Authors:  Peter Adolfsson; Christopher G Parkin; Andreas Thomas; Lars G Krinelke
Journal:  Eur Endocrinol       Date:  2018-04-18

Review 5.  Glycemic variability: adverse clinical outcomes and how to improve it?

Authors:  Zheng Zhou; Bao Sun; Shiqiong Huang; Chunsheng Zhu; Meng Bian
Journal:  Cardiovasc Diabetol       Date:  2020-07-04       Impact factor: 9.951

6.  Study protocol for optimising glycaemic control in type 1 diabetes treated with multiple daily insulin injections: intermittently scanned continuous glucose monitoring, carbohydrate counting with automated bolus calculation, or both? A randomised controlled trial.

Authors:  Anna Lilja Secher; Ulrik Pedersen-Bjergaard; Ole Lander Svendsen; Birthe Gade-Rasmussen; Thomas P Almdal; Liv Dørflinger; Dorte Vistisen; Kirsten Nørgaard
Journal:  BMJ Open       Date:  2020-04-27       Impact factor: 2.692

Review 7.  Improving patient self-care using diabetes technologies.

Authors:  Valeria Alcántara-Aragón
Journal:  Ther Adv Endocrinol Metab       Date:  2019-01-28       Impact factor: 3.565

Review 8.  Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications.

Authors:  Bao Sun; Zhiying Luo; Jiecan Zhou
Journal:  Cardiovasc Diabetol       Date:  2021-01-07       Impact factor: 9.951

Review 9.  Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment.

Authors:  Theresa Meldgaard; Søren Schou Olesen; Adam D Farmer; Klaus Krogh; Anne Astrid Wendel; Birgitte Brock; Asbjørn Mohr Drewes; Christina Brock
Journal:  J Diabetes Res       Date:  2018-09-16       Impact factor: 4.011

10.  Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale.

Authors:  Simona de Portu; Linda Vorrink; Roseline Re; John Shin; Javier Castaneda; Aklilu Habteab; Ohad Cohen
Journal:  BMJ Open       Date:  2022-02-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.